SPY766.62−0.02%QQQ689.02−0.42%BTC/USD80,646.79+0.27%DIA534.30+0.22%GLD374.79+0.62%TLT81.92+0.20%

Premium Services

Premium Services

IGC Pharma Inc

IGCAMEX

Trade with Public

Trade with Public

$0.1950

0.0094.84%

Last update: Nov 4, 7:56 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

IGC Pharma (IGC) Stock Price Target 2026 & Analyst Forecast - Benzinga

IGC Pharma (IGC) Stock Price Target 2026

The average analyst price target for IGC Pharma is $4.75, 2276.2% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $3.50 to $6. The latest change came on Aug 26, 2026, when Ascendiant Capital raised its price target on IGC Pharma from $5.50 to $6 and kept a Buy rating.

The Average Analyst Price Target for IGC Pharma is $4.75.

Price Target Range — 9 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$4.75Upside to Avg. PT+2276.2%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for IGC Pharma Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 26, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$6→$6
Jun 8, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$6
Apr 8, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$5
Feb 23, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$5
Dec 9, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$5→$5
Aug 26, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$5
Mar 6, 2025	Alliance Global Partners	James Molloy	Maintained	Buy	$4
Feb 24, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Dec 5, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Sep 3, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$4→$4
Jul 29, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$3→$4
Jul 17, 2024	Alliance Global Partners	James Molloy	Initiate	Buy	$4
Jun 21, 2024	Ascendiant Capital	Edward Woo	Maintained	Buy	$3

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $6

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5.5 to $6.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5.25 to $5.5.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.25

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5 to $5.25.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.75 to $5.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $4.5.

Benzinga Newsdesk

PRO
Alliance Global Partners Reiterates Buy on IGC Pharma, Maintains $3.5 Price Target

Alliance Global Partners analyst James Molloy reiterates IGC Pharma (AMEX:IGC) with a Buy and maintains $3.5 price target.

Benzinga Newsdesk